Kevin Kratiuk

发表

Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, CNS Drugs.

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.

A. Young, M. Thase, S. Stahl, 2021, The American journal of psychiatry.

Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychopharmacology.

A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.

Nelson B Rodrigues, R. McIntyre, M. Vinberg, 2020, Journal of affective disorders.

Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2023, Psychiatry Research.

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Expert opinion on drug safety.

The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date

R. McIntyre, Renee-Marie Ragguett, Carola Rong, 2018, Expert opinion on investigational drugs.

Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

Nelson B Rodrigues, T. Suppes, A. Fagiolini, 2020, Bipolar disorders.

The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, CNS Spectrums.

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2023, Journal of psychopharmacology.

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychopharmacology.

Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of psychiatric research.

Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of sleep research.

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, CNS Spectrums.

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study

Nelson B Rodrigues, R. McIntyre, B. Fehnert, 2022, JMIR mental health.

Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychiatric research.